Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ruxolitinib phosphate

Known as: (3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile Phosphate (1:1), 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-, phosphate (1:1), INCB-18424 Phosphate 
The phosphate salt form of ruxolitinib, an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
ABSTRACT Introduction Allogeneic transplantation represents a potentially curative procedure for various lethal conditions… Expand
Is this relevant?
2019
2019
e19063Background: Constitutive activation of the JAK-STAT pathway has been reported in lymphomas, suggesting that targeting this… Expand
Is this relevant?
Review
2016
Review
2016
PURPOSE To review the use of patient-reported outcome (PRO) data in medical product labeling granted by the US Food and Drug… Expand
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2012
Review
2012
Abstract Objective To provide information regarding the most important properties of the new therapeutic agents marketed in the… Expand
  • table 1
Is this relevant?